Additionally, we sought to translate the correlative molecular biomarkers of ASS1 deficiency in non‐squamous NSCLC by next‐generation sequencing, characterize the levels of PD‐L1 expression immunohistochemically, and explore the treatment resistance. This evidence concerns the gene CD274 and non-small cell lung carcinoma.